Zencurix "CEO Jo Sang-rae Joins Children's Traffic Safety Relay Challenge"
[Asia Economy Reporter Hyunseok Yoo] GenCurix announced on the 31st that it has joined the "Children's Traffic Safety Relay Challenge" organized by the Ministry of the Interior and Safety.
This campaign was initiated with the purpose of preventing traffic accidents in school zones and establishing a driving culture that prioritizes child protection, thereby forming a national consensus. It promotes the slogan "Stop at 1 step, look both ways at 2 sides, wait for 3 seconds, prevent 4 dangers" to prevent the most common type of child traffic accident, "accidents while crossing," and to ensure children can cross safely.
Jangrae Cho, CEO of GenCurix, said, "Although efforts to enhance children's traffic safety, such as strengthening speed limits in school zones, continue, it is very regrettable whenever news of traffic accidents in these zones is heard. Protecting children is the duty of us adults, so I hope this campaign becomes an opportunity for many adults to take greater interest in children's traffic safety and accident prevention."
This campaign proceeds by sharing the children's traffic safety slogan and nominating the next participants. CEO Jangrae Cho was nominated by Mansoon Hwang, CEO of Korea Investment Partners. He nominated Youngjun Park, CEO of The Nature Holdings, Chaechul Choi, CEO of Ngenbio, and Sunwoo Kim, CEO of DeepBio as the next participants.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Contracts Signed Without Viewing at 1.6 Billion Won"... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- [Breaking] Blue House expresses "deep regret over Samsung negotiation breakdown... urges both sides to do their best for a final agreement"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Meanwhile, GenCurix is a technology company developing molecular diagnostic tests based on core technologies for liquid biopsy and biomarker discovery. Its representative products include the "Breast Cancer Prognosis Test (GenesWell BCT)" and the "Lung Cancer Companion Diagnostic (GenesWell ddEGFR Mutation Test)." Following the company's vision to develop technology to improve the quality of life for cancer patients, it has also produced an Instagram cartoon titled "Things That Become Visible Only Then" and is conducting a breast cancer awareness campaign.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
